ISDA

Entry Detail

PDB ID:

6NCJ

Keywords:

VIRAL PROTEIN

Title:

Structure of HIV-1 Integrase with potent 5,6,7,8-Tetrahydro-1,6-naphthyridine Derivatives Allosteric Site Inhibitors

Biological Source:

Source Organism:

Human immunodeficiency virus 1

Host Organism:

Escherichia coli BL21(DE3)

PDB Version:

Deposition Date:

2018-12-11

Release Date:

2019-01-16

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.00 Å

R-Value Free:

0.24

R-Value Work:

0.19

R-Value Observed:

0.19

Space Group:

P 31 2 1

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:Integrase
Mutations:C56S, F139D, F185H
Chain IDs:A
Chain Length:180
Number of Molecules:1
Biological Source:Human immunodeficiency virus 1

UniProt ID:F2WR52 Pfam ID:PF00665

Ligand Molecules

EDO

KJJ

SO4

Primary Citation

5,6,7,8-Tetrahydro-1,6-naphthyridine Derivatives as Potent HIV-1-Integrase-Allosteric-Site Inhibitors.

Peese, K.M, Allard, C.W, Connolly, T, Johnson, B.L, Li, C, Patel, M, Sorensen, M.E, Walker, M.A, Meanwell, N.A, McAuliffe, B, Minassian, B, Krystal, M, Parker, D.D, Lewis, H.A, Kish, K, Zhang, P, Nolte, R.T, Simmermacher, J, Jenkins, S, Cianci, C, Naidu, B.N.Show

J. Med. Chem. 62 1348 1361 (2019)

PMID: 30609350 DOI: 10.1021/acs.jmedchem.8b01473

Abstact

A series of 5,6,7,8-tetrahydro-1,6-naphthyridine derivatives targeting the allosteric lens-epithelium-derived-growth-factor-p75 (LEDGF/p75)-binding site on HIV-1 integrase, an attractive target for antiviral chemotherapy, was prepared and screened for activity against HIV-1 infection in cell culture. Small molecules that bind within the LEDGF/p75-binding site promote aberrant multimerization of the integrase enzyme and are of significant interest as HIV-1-replication inhibitors. Structure-activity-relationship studies and rat pharmacokinetic studies of lead compounds are presented.

Legend

Protein

Chemical

Disease

Primary Citation of related structures